{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:50:27Z","timestamp":1791402627045,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.1007\/s12602-017-9372-9","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T05:51:19Z","timestamp":1518501079000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of VSL#3 Probiotic in a Patient with Glycogen Storage Disease Type Ia and Irritable Bowel Disease-like Disease"],"prefix":"10.1007","volume":"11","author":[{"given":"Miguel","family":"Carnero-Gregorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Molares-Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberte","family":"Corbal\u00e1n-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Villaverde-Taboada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9939-0771","authenticated-orcid":false,"given":"Carmen","family":"Rodr\u00edguez-Cerdeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"9372_CR1","first-page":"1521","volume-title":"The metabolic & molecular bases of inherited disease","author":"YT Chen","year":"2001","unstructured":"Chen YT (2001) Glycogen storage diseases. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic & molecular bases of inherited disease. McGraw-Hill, New York, pp 1521\u20131551"},{"issue":"4","key":"9372_CR2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0022-3476(69)80459-2","volume":"75","author":"RN Fine","year":"1969","unstructured":"Fine RN, Kogut MD, Donnell GN (1969) Intestinal absorption in type I glycogen storage disease. J Pediatr 75(4):632\u2013635. \nhttps:\/\/doi.org\/10.1016\/S0022-3476(69)80459-2","journal-title":"J Pediatr"},{"issue":"2","key":"9372_CR3","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/MPG.0000000000000592","volume":"64","author":"NT Lawrence","year":"2017","unstructured":"Lawrence NT, Chengsupanimit T, Brown LM, Derks TGJ, Smit GPA, Weinstein DA (2017) Inflammatory bowel disease in glycogen storage disease type Ia. J Pediatr Gastroenterol Nutr 64(2):e52\u2013e54. \nhttps:\/\/doi.org\/10.1097\/MPG.0000000000000592","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9372_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/8904_2015_452","volume":"24","author":"NT Lawrence","year":"2015","unstructured":"Lawrence NT, Chengsupanimit T, Brown LM, Weinstein DA (2015) High incidence of serologic markers of inflammatory bowel disease in asymptomatic patients with glycogen storage disease type Ia. JIMD Rep 24:123\u2013128. \nhttps:\/\/doi.org\/10.1007\/8904_2015_452","journal-title":"JIMD Rep"},{"issue":"7152","key":"9372_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature06005","volume":"448","author":"RJ Xavier","year":"2007","unstructured":"Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448(7152):427\u2013434. \nhttps:\/\/doi.org\/10.1038\/nature06005","journal-title":"Nature"},{"issue":"3","key":"9372_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.phrs.2009.11.001","volume":"61","author":"JM Laparra","year":"2010","unstructured":"Laparra JM, Sanz Y (2010) Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res 61(3):219\u2013225. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2009.11.001","journal-title":"Pharmacol Res"},{"issue":"5","key":"9372_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.phrs.2011.02.006","volume":"63","author":"P Aureli","year":"2011","unstructured":"Aureli P, Capurso L, Castellazzi AM, Clerici M, Giovannini M, Morelli L, Poli A, Pregliasco F, Salvini F, Zuccotti GV (2011) Probiotics and health: an evidence-based review. Pharmacol Res 63(5):366\u2013376. \nhttps:\/\/doi.org\/10.1016\/j.phrs.2011.02.006","journal-title":"Pharmacol Res"},{"issue":"5","key":"9372_CR8","doi-asserted-by":"publisher","first-page":"A198","DOI":"10.1289\/ehp.117-a198","volume":"117","author":"ML Phillips","year":"2009","unstructured":"Phillips ML (2009) Gut reaction: environmental effects on the human microbiota. Environ Health Perspect 117(5):A198\u2013A205. \nhttps:\/\/doi.org\/10.1289\/ehp.117-a198","journal-title":"Environ Health Perspect"},{"issue":"7285","key":"9372_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dor\u00e9 J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, MetaHIT Consortium, Bork P, Ehrlich SD, Wang J (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59\u201365. \nhttps:\/\/doi.org\/10.1038\/nature08821","journal-title":"Nature"},{"issue":"6","key":"9372_CR10","doi-asserted-by":"publisher","first-page":"679S","DOI":"10.1080\/07315724.2007.10719647","volume":"26","author":"KA Tappenden","year":"2007","unstructured":"Tappenden KA, Deutsch AS (2007) The physiological relevance of the intestinal microbiota\u2014contributions to human health. J Am Coll Nutr 26(6):679S\u2013683S","journal-title":"J Am Coll Nutr"},{"issue":"Pt17","key":"9372_CR11","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1113\/jphysiol.2009.176370","volume":"587","author":"SC Resta","year":"2009","unstructured":"Resta SC (2009) Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol 587(Pt17):4169\u20134174. \nhttps:\/\/doi.org\/10.1113\/jphysiol.2009.176370","journal-title":"J Physiol"},{"issue":"6","key":"9372_CR12","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1038\/nutd.2015.9","volume":"5","author":"LK Brahe","year":"2015","unstructured":"Brahe LK, Chatelier EL, Prifti E, Brahe LK, Chatelier EL, Prifti E, Pons N, Kennedy S, Hansen T, Pedersen O, Astrup A, Ehrlich SD, Larsen LH (2015) Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diab 5(6):e159. \nhttps:\/\/doi.org\/10.1038\/nutd.2015.9","journal-title":"Nutr Diab"},{"issue":"2","key":"9372_CR13","doi-asserted-by":"publisher","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","volume":"5","author":"N Larsen","year":"2010","unstructured":"Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, S\u00f8rensen SJ, Hansen LH, Jakobsen M (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2):e9085. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0009085","journal-title":"PLoS One"},{"issue":"2","key":"9372_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/MOG.0b013e32835d7bba","volume":"29","author":"K Whelan","year":"2013","unstructured":"Whelan K, Quigley EM (2013) Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 29(2):184\u2013189. \nhttps:\/\/doi.org\/10.1097\/MOG.0b013e32835d7bba","journal-title":"Curr Opin Gastroenterol"},{"key":"9372_CR15","doi-asserted-by":"publisher","first-page":"435268","DOI":"10.1155\/2013\/435268","volume":"2013","author":"F Scaldaferri","year":"2013","unstructured":"Scaldaferri F, Gerardi V, Lopetuso LR, Zompo FD, Mangiola F, Bo\u0161koski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A (2013) Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int 2013:435268\u2013435269. \nhttps:\/\/doi.org\/10.1155\/2013\/435268","journal-title":"Biomed Res Int"},{"issue":"4","key":"9372_CR16","doi-asserted-by":"publisher","first-page":"e34938","DOI":"10.1371\/journal.pone.0034938","volume":"7","author":"ML Ritchie","year":"2012","unstructured":"Ritchie ML, Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7(4):e34938. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0034938","journal-title":"PLoS One"},{"issue":"3","key":"9372_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijfoodmicro.2011.07.005","volume":"149","author":"CP Champagne","year":"2011","unstructured":"Champagne CP, Ross RP, Saarela M, Hansen KF, Charalampopoulos D (2011) Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices. Int J Food Microbiol 149(3):185\u2013193. \nhttps:\/\/doi.org\/10.1016\/j.ijfoodmicro.2011.07.005","journal-title":"Int J Food Microbiol"},{"issue":"1","key":"9372_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12879-017-2727-8","volume":"17","author":"LM Abayasekara","year":"2017","unstructured":"Abayasekara LM, Perera J, Chandrasekharan V, Gnanam VS, Udunuwara NA, Liyanage DS, Bulathsinhala NE, Adikary S, Aluthmuhandiram JVS, Thanaseelan CS, Tharmakulasingam DP, Karunakaran T, Ilango J (2017) Detection of bacterial pathogens from clinical specimens using conventional microbial culture and 16S metagenomics: a comparative study. BMC Infect Dis 17(1):631. \nhttps:\/\/doi.org\/10.1186\/s12879-017-2727-8","journal-title":"BMC Infect Dis"},{"key":"9372_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jaut.2017.07.004","volume":"85","author":"M Argollo","year":"2017","unstructured":"Argollo M, Fiorino G, Hindryckx P, Peyrin-Biroulet L, Danese S (2017) Novel therapeutic targets for inflammatory bowel disease. J Autoimmun 85:103\u2013116. \nhttps:\/\/doi.org\/10.1016\/j.jaut.2017.07.004","journal-title":"J Autoimmun"},{"key":"9372_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S095442241700018X","volume":"17","author":"YA Kim","year":"2017","unstructured":"Kim YA, Keogh JB, Clifton PM (2017) The anti-diabetic effects of probiotics include reducing pro-inflammatory cytokines via a NF-\u03baB pathway, reduced intestinal permeability, and lowered oxidative stress. Nutr Res Rev 17:1\u201317. \nhttps:\/\/doi.org\/10.1017\/S095442241700018X","journal-title":"Nutr Res Rev"},{"issue":"33","key":"9372_CR21","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.3748\/wjg.v16.i33.4145","volume":"16","author":"SK Hegazy","year":"2010","unstructured":"Hegazy SK, El-Bedewy MM (2010) Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol 16(33):4145\u20134151. \nhttps:\/\/doi.org\/10.3748\/wjg.v16.i33.4145","journal-title":"World J Gastroenterol"},{"issue":"4","key":"9372_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.gtc.2017.08.004","volume":"46","author":"HE Rasmussen","year":"2017","unstructured":"Rasmussen HE, Hamaker BR (2017) Prebiotics and inflammatory bowel disease. Gastroenterol Clin N Am 46(4):783\u2013795. \nhttps:\/\/doi.org\/10.1016\/j.gtc.2017.08.004","journal-title":"Gastroenterol Clin N Am"},{"issue":"5","key":"9372_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S1665-2681(19)31246-3","volume":"13","author":"C Buss","year":"2014","unstructured":"Buss C, Valle-Tovo C, Miozzo S, Alves de Mattos A (2014) Probiotics and synbiotics mayimprove liver aminotransferases levels in non-alcoholic fatty liver disease patients. Ann Hepatol 13(5):482\u2013488","journal-title":"Ann Hepatol"},{"issue":"8","key":"9372_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","volume":"42","author":"IA Kirpich","year":"2008","unstructured":"Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, Bazhukova TA, Soloviev AG, Barve SS, McClain CJ, Cave M (2008) Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42(8):675\u2013682. \nhttps:\/\/doi.org\/10.1016\/j.alcohol.2008.08.006","journal-title":"Alcohol"},{"key":"9372_CR25","doi-asserted-by":"publisher","unstructured":"Khalesi S, Johnson DW, Campbell K, Williams S, Fenning A, Saluja S, Irwin C (2017) Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis. Eur J Nutr. \nhttps:\/\/doi.org\/10.1007\/s00394-017-1568-y","DOI":"10.1007\/s00394-017-1568-y"},{"issue":"4","key":"9372_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/17474124.2017.129212","volume":"11","author":"P Ministro","year":"2017","unstructured":"Ministro P, Martins D (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why? Expert Rev Gastroenterol Hepatol 11(4):317\u2013328. \nhttps:\/\/doi.org\/10.1080\/17474124.2017.129212","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"9372_CR27","doi-asserted-by":"publisher","unstructured":"Conroy S, Hale MF, Cross SS, Swallow K, Sidhu RH, Sargur R, Lobo AJ (2017) Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care. J Clin Pathol. \nhttps:\/\/doi.org\/10.1136\/jclinpath-2017-204506","DOI":"10.1136\/jclinpath-2017-204506"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12602-017-9372-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-017-9372-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-017-9372-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T14:34:45Z","timestamp":1600094085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12602-017-9372-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3,15]]}},"alternative-id":["9372"],"URL":"https:\/\/doi.org\/10.1007\/s12602-017-9372-9","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"13 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that there are no competing interests regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"Right to privacy and informed consent. The authors have obtained informed consent of the patients and\/or subjects referred to in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Responsibilities"}}]}}